MedTech News

PathAI receives FDA clearance for AISight Dx platform

PathAI, a global leader in artificial intelligence (AI) and digital pathology solutions, has announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for AISight Dx—its digital pathology image management system—for use in primary diagnosis in clinical settings.

Read More »

Sign up for Blog Updates